2019
DOI: 10.1016/j.dsx.2018.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Association of acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…Although baseline C3a was approximately 9% higher in men with abdominal obesity compared with lean men, this difference was not statistically significant. Previous publications have reported higher C3a in people with obesity than in lean individuals, but these reports have often concerned studies in persons with extreme levels of obesity, with obesity-related comorbidities such as metabolic syndrome, and/or with larger numbers of participants (15,(36)(37)(38). This may explain why our current findings that C3a did not change upon a weight-loss intervention in men with abdominal obesity contrasts with a previous report that, in women, plasma C3a was reduced upon extreme weight loss resulting from bariatric surgery (38).…”
Section: Discussionmentioning
confidence: 99%
“…Although baseline C3a was approximately 9% higher in men with abdominal obesity compared with lean men, this difference was not statistically significant. Previous publications have reported higher C3a in people with obesity than in lean individuals, but these reports have often concerned studies in persons with extreme levels of obesity, with obesity-related comorbidities such as metabolic syndrome, and/or with larger numbers of participants (15,(36)(37)(38). This may explain why our current findings that C3a did not change upon a weight-loss intervention in men with abdominal obesity contrasts with a previous report that, in women, plasma C3a was reduced upon extreme weight loss resulting from bariatric surgery (38).…”
Section: Discussionmentioning
confidence: 99%
“…The impact of ASP and its association with insulin resistance in obese individuals have been extensively researched through various studies. These investigations have assessed parameters such as homeostatic model assessment of insulin resistance (HOMA‐IR), plasma glucose levels and insulin, ultimately establishing a link between ASP and insulin resistance in this population (Castellano‐Castillo et al., 2018; Mishra et al., 2019; Ursini & Abenavoli, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…ASP in circulation increases substantially with overweight and obesity and declines with weight loss. ASP levels are correlated with cardiometabolic risk markers in obese people (Al‐Kuraishy & Al‐Gareeb, 2017; Mishra et al., 2019; Onat et al., 2017). ASP and its component proteins (C3, factor B and adipsin) have been demonstrated to be meaningfully increased in type 2 diabetes as well as in some research on type I diabetes (Cianflone et al., 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Different adipocytokines are secreted by adipose tissue, and these hormonal alterations play a key role in metabolic diseases. (9) Leptin and adiponectin are adipocytokines, hormones mainly produced by adipose tissue and responsible for regulating lipid metabolism, insulin resistance and inflammation. (10) While interleukin 6 (IL-6) is a pro-inflammatory cytokine and an anti-inflammatory myokine.…”
Section: Introductionmentioning
confidence: 99%